资源类型:
收录情况:
◇ SCIE
◇ CPCI(ISTP)
文章类型:
作者:
Chen, Suning[1]
*
;
Zhang, Yanli[2]
;
Xu, Na[3]
;
Sun, Hui[4]
;
Li Weiming[5]
;
Yang, Yunfan[6]
;
Zhu, Zunmin[7]
;
Duan, Minghui[8]
;
Qian, Sixuan[9]
;
Zhu, Yu[9]
;
Luo, Jianmin[10]
;
Wang, Xiaodong[11]
;
Yang, Wei[12]
;
Gu, Weiying[13]
;
Li, Fei[14]
;
Liu, Bingcheng[15,16]
;
Xu, Yunxiao[17]
;
Liu, Zhenfang[18]
;
Wang, Chunling[19]
;
Jiang, Yirong[20]
;
Meng, Li[21]
;
Wen, Qin[22]
;
Xu, Yanli[23]
;
Zou, Xingli[24]
;
Wang, Wei[25]
;
Xue, Yan[26]
;
Xu, Hao[27]
;
Bi, Kehong[28]
;
Zhou, Fuling[29]
;
Ma, Liangming[30]
;
Fu, Rong[31]
;
Ouyang, Guifang[32]
;
Ding, Kaiyang[33]
;
Wu, Depei[34]
;
单位:
[1]Soochow Univ, Jiangsu Inst Hematol, Affiliated Hosp 1, Collaborat Innovat Ctr Hematol,Natl Clin Res Ctr, Suzhou, Peoples R China
[2]Henan Canc Hosp, Dept Hematol, Zhengzhou, Peoples R China
河南省肿瘤医院
[3]Southern Med Univ, Nanfang Hosp, Dept Hematol, Guangzhou, Peoples R China
[4]Zhengzhou Univ, Dept Hematol, Affiliated Hosp 1, Zhengzhou, Peoples R China
[5]Huazhong Univ Sci & Technol, Union Hosp, Dept Hematol, Tongji Med Coll, Wuhan, Peoples R China
华中科技大学同济医学院附属协和医院
[6]Sichuan Univ, Dept Hematol, West China Hosp, Chengdu, Peoples R China
四川大学华西医院
[7]Henan Prov Peoples Hosp, Dept Hematol, Zhengzhou, Peoples R China
[8]Chinese Acad Med Sci, Dept Hematol, Peking Union Med Coll Hosp, Beijing, Peoples R China
[9]Jiangsu Prov Peoples Hosp, Dept Hematol, Nanjing, Peoples R China
江苏省人民医院
[10]Hebe Med Univ, Dept Hematol, Hosp 2, Shijiazhuang, Hebei, Peoples R China
[11]Sichuan Prov Peoples Hosp, Dept Hematol, Chengdu, Peoples R China
四川省人民医院
[12]China Med Univ, Dept Hematol, Shengjing Hosp, Shenyang, Peoples R China
中国医科大学附属盛京医院
中国医科大学盛京医院
[13]Changzhou First Peoples Hosp, Dept Hematol, Changzhou, Jiangsu, Peoples R China
[14]Nanchang Univ, Dept Hematol, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China
[15]Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol, Natl Clin Res Ctr Blood Dis, State Key Lab Expt Hematol,Haihe Lab Cell Ecosyst, Tianjin, Peoples R China
[16]Chinese Acad Med Sci & Peking Union Med Coll, Blood Dis Hosp, Tianjin, Peoples R China
[17]Cent South Univ, Dept Hematol, Xiangya Hosp 2, Changsha, Peoples R China
[18]Guangxi Med Univ, Dept Hematol, Affiliated Hosp 1, Nanning, Peoples R China
[19]Huaian First Peoples Hosp, Dept Hematol, Huaian, Peoples R China
[20]Southern Med Univ, Dept Hematol, Dongguan Hosp, Dongguan, Peoples R China
[21]Huazhong Univ Sci & Technol, Tongji Hosp, Dept Hematol, Tongji Med Coll, Wuhan, Peoples R China
内科学系
血液内科
华中科技大学同济医学院附属同济医院
[22]Army Med Univ, Xinqiao Hosp, Med Ctr Hematol, State Key Lab Trauma Burn & Combined Injury, Chongqing, Peoples R China
[23]Nanjing First Hosp, Dept Hematol, Nanjing, Peoples R China
[24]North Sichuan Med Coll, Dept Hematol, Affiliated Hosp, Nanchong, Peoples R China
[25]Qingdao Univ, Dept Hematol, Affiliated Hosp, Qingdao, Peoples R China
[26]Xuzhou Cent Hosp, Dept Hematol, Xuzhou, Jiangsu, Peoples R China
[27]Yancheng First Peoples Hosp, Dept Hematol, Yancheng, Peoples R China
[28]Shandong First Med Univ, Dept Hematol, Affiliated Hosp 1, Jinan, Peoples R China
[29]Wuhan Univ, Dept Hematol, Zhongnan Hosp, Wuhan, Peoples R China
[30]Shanxi Bethune Hosp, Dept Hematol, Taiyuan, Peoples R China
[31]Tianjin Med Univ, Dept Hematol, Gen Hosp, Tianjin, Peoples R China
[32]Ningbo First Hosp, Dept Hematol, Ningbo, Peoples R China
[33]Univ Sci & Technol China, Dept Hematol, Affiliated Hosp 1, Hefei, Peoples R China
[34]Soochow Univ, Affiliated Hosp 1, Suzhou, Peoples R China
ISSN:
WOS:
中科院(CAS)分区:
出版当年[2022]版:
大类
|
1 区
医学
小类
|
1 区
血液学
最新[2025]版:
大类
|
1 区
医学
小类
|
1 区
血液学
JCR分区:
出版当年[2021]版:
Q1
HEMATOLOGY
影响因子:
最新[2023版]
最新五年平均
出版当年[2021版]
出版当年五年平均
出版前一年[2020版]
出版后一年[2022版]
第一作者:
第一作者单位:
[1]Soochow Univ, Jiangsu Inst Hematol, Affiliated Hosp 1, Collaborat Innovat Ctr Hematol,Natl Clin Res Ctr, Suzhou, Peoples R China
推荐引用方式(GB/T 7714):
Chen Suning,Zhang Yanli,Xu Na,et al.Flumatinib Versus Nilotinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia[J].BLOOD.2023,142:doi:10.1182/blood-2023-179073.
APA:
Chen, Suning,Zhang, Yanli,Xu, Na,Sun, Hui,Li Weiming...&Wu, Depei.(2023).Flumatinib Versus Nilotinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia.BLOOD,142,
MLA:
Chen, Suning,et al."Flumatinib Versus Nilotinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia".BLOOD 142.(2023)